about
sameAs
The epigenetic landscape of acute myeloid leukemiaCancer genome landscapesASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repressionThe R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramersA decade of exploring the cancer epigenome - biological and translational implicationsDownstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implicationsNetwork of Cancer Genes (NCG 3.0): integration and analysis of genetic and network properties of cancer genesGenetic and epigenetic mechanisms in the development of arteriovenous malformations in the brainModifiers and Readers of DNA Modifications and Their Impact on Genome Structure, Expression, and Stability in DiseaseEpimutational profile of hematologic malignancies as attractive target for new epigenetic therapiesMolecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted TherapyEpigenetic regulators and their impact on therapy in acute myeloid leukemiaEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionUpdate on rational targeted therapy in AMLAcute Myeloid Leukemia: A Concise ReviewEmerging technologies in paediatric leukaemiaMolecular landscape of acute myeloid leukemia in younger adults and its clinical relevanceInterplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in LeukemiaTowards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implicationsThe complexity of epigenetic diseasesGenomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid LeukemiaPediatric AML: From Biology to Clinical ManagementVolasertib for AML: clinical use and patient considerationNew and emerging factors in tumorigenesis: an overviewInduced pluripotent stem cell technology for dissecting the cancer epigenomeEpigenomics of leukemia: from mechanisms to therapeutic applicationsFrom human genome to cancer genome: the first decadeSerine, glycine and one-carbon units: cancer metabolism in full circleGenomic profiling of B-progenitor acute lymphoblastic leukemiaEpigenomics of cancer - emerging new conceptsNew answers to old questions from genome-wide maps of DNA methylation in hematopoietic cellsCytosine modifications in neurodevelopment and diseasesPerioperative genomicsApplications of next-generation sequencing to blood and marrow transplantationGenomic sequencing in cancerMechanisms of epigenetic regulation of leukemia onset and progressionPost-remission therapy for acute myeloid leukemiaGenome sequencing and cancerMolecular prognostic factors in cytogenetically normal acute myeloid leukemiaMyeloid malignancies: mutations, models and management
P2860
Q21284742-5D645BCB-F00C-4D6D-B674-4C4E0172DA34Q22242276-12B133B3-2A88-4129-80BC-35B8C6D8D1BEQ24296658-E88DCE8E-88AB-4478-9F2C-CD7AF067F243Q24339485-98261955-D35B-4912-BFD5-F33D3D85C175Q24614467-F1F2398A-3747-4C1A-AD56-A16A2136037CQ24617091-9E1F38E3-EACA-46E2-9437-F678D0A7E106Q24619351-5A916CB5-ECA8-4B2E-AACD-66A8E7E43CAEQ26741878-8510E600-2F87-452D-B0C6-BBA7721533ECQ26742136-90C807AC-414A-4094-A31E-1636C5A6469CQ26744080-109B1C47-1352-45F1-B5B3-A40D910216DBQ26749870-B5B5026F-4B6C-494D-BB7B-2155AD397022Q26765402-47D16CF1-57AD-40AA-B529-5A18388B306BQ26766149-0FD629D2-79D0-4BBE-AEDD-5F32CF975731Q26766152-FA03BBF8-4EB7-454C-80F2-DDD8FA91CAA3Q26766719-09942523-9CE5-4A18-868B-9ABB1495C088Q26770327-A6905C69-D595-4A08-8D3D-2131E995A4D7Q26776393-6313DBAA-76F7-44DA-943E-59A30DD66D96Q26781526-4849D26D-A3F0-4EAD-8E52-C52535C3B085Q26783490-D6693CFA-A3C3-4630-A2C7-0508A7EBE7E5Q26784416-682DAAFA-35E2-448A-94C8-BC17E8A7E629Q26796514-9F5A4AEA-7433-46F1-ACF4-E5360E358291Q26799773-06E09EBC-6C53-412E-8694-F04D730635BEQ26801131-A9462E3A-44C3-421A-8794-A11E827F5461Q26801253-50BF63E6-8AA8-4E56-BA36-E64FA64D683BQ26801711-A86285AD-A2BF-4B34-907B-E04302996552Q26823403-23F37849-1B74-4D74-98E9-9BF013A875BBQ26827640-5FCF4447-6BDA-4087-9C77-AC00A9F39BC1Q26828610-CD8CA1B4-B326-4FD3-83E6-7EB6BE305F7DQ26829976-87AFA4F9-763F-457B-AC60-2E84FA98DCEFQ26830534-7FCFC35F-FE64-4C32-BFE9-D6CE4100DCBFQ26851510-D38F7CB0-2151-4BA4-A177-DEC591F6E751Q26852087-2D3E592C-5F08-4896-A879-397A3FDF1524Q26852636-60955AAA-ADD6-4ACE-BFE5-A7433E9DE545Q26852890-BC9D17E0-AF68-44A0-988C-62C61C9458C3Q26853507-87AE8D03-58E4-4562-9ABA-0D9ABFC80C2AQ26861785-73CBBDCF-927D-4E0F-A09E-CD97AE11706FQ26995867-3E583B01-4C0F-472A-9CC0-B9004A99D9E7Q26998499-135E445C-6F91-4E5B-A878-C3460988F1D0Q26998811-F9F0605E-A662-462C-92B6-7CC2E5C7954BQ27000577-837635E6-E166-4438-A208-52F82DCF3A06
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
DNMT3A Mutations in Acute Myeloid Leukemia
@ast
DNMT3A Mutations in Acute Myeloid Leukemia
@en
DNMT3A Mutations in Acute Myeloid Leukemia
@nl
type
label
DNMT3A Mutations in Acute Myeloid Leukemia
@ast
DNMT3A Mutations in Acute Myeloid Leukemia
@en
DNMT3A Mutations in Acute Myeloid Leukemia
@nl
altLabel
DNMT3A mutations in acute myeloid leukemia
@en
DNMT3AMutations in Acute Myeloid Leukemia
@en
prefLabel
DNMT3A Mutations in Acute Myeloid Leukemia
@ast
DNMT3A Mutations in Acute Myeloid Leukemia
@en
DNMT3A Mutations in Acute Myeloid Leukemia
@nl
P2093
P2860
P50
P3181
P356
P1476
DNMT3A mutations in acute myeloid leukemia
@en
DNMT3AMutations in Acute Myeloid Leukemia
@en
P2093
Cheryl F Lichti
Christopher C Harris
Daniel C Koboldt
Daniel C Link
David E Larson
David J Dooling
Gary W Swift
Heather Schmidt
Jacqueline E Payton
P2860
P304
P3181
P356
10.1056/NEJMOA1005143
P407
P5008
P577
2010-12-16T00:00:00Z